Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BNTX crawled time : 15:00 save search
BTI Investors Have Opportunity to Lead British American Tobacco p.l.c. Securities Fraud Lawsuit
Published: 2024-02-20 (Crawled : 15:00) - prnewswire.com
MBLY | $30.21 -2.49% -2.55% 2.2M
|
|
| O: -0.12%
H: 0.31%
C: -1.25%
BTAFF | $28.176 44.6% 1.8K
|
Consumer Non-Durables
|
| O: 1.78%
H: 0.47%
C: -1.11%
BTI | $29.05 0.8% -0.07% 5.6M
|
Consumer Non-Durables
|
| O: -1.54%
H: 1.12%
C: 0.9%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.28%
H: 2.34%
C: 0.82%
Pomerantz LLP Announces Notice of Pendency of Class Action and Proposed Settlement of Class Action in the In re iAnthus Capital Holdings, Inc. Securities Litigation
Published: 2024-01-22 (Crawled : 15:00) - prnewswire.com
ITHUF | $0.0176 -10.56% 7.1K
|
Process Industries
|
| O: -18.81%
H: 25.0%
C: 25.0%
ABR | $12.62 1.12% 0.24% 3.1M
|
Finance
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.54%
C: 1.44%
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Genmab Announces Financial Results for the First Half of 2023
Published: 2023-08-03 (Crawled : 15:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.24%
H: 1.29%
C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.25%
H: 1.87%
C: 1.52%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.25%
H: 3.13%
C: 1.84%
financial results
Immune Checkpoint Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Key Companies in the Market - Regeneron, GlaxoSmithKline, Roche, Boehringer Ingelheim, AstraZeneca, Seagen, Roche
Published: 2023-06-13 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: -1.27%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.71%
H: 0.0%
C: -1.32%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.22%
H: 0.69%
C: 0.04%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.92%
H: 0.32%
C: -0.41%
NXTC | $1.67 6.37% 5.99% 62K
|
Health Technology
|
| O: -2.99%
H: 4.32%
C: 1.85%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.48%
H: 1.44%
C: 0.24%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.18%
H: 5.8%
C: 5.1%
companies roche growth market
Melanoma Market to Witness Promising Growth, Predicts DelveInsight | Key Companies To Watch - IO Biotech, Merck, Eisai, Regeneron, Genentech, Seagen, Amgen, Astellas, Galectin, MedImmune, Aivita, Linnaeus, Checkmate, OnKure
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
PVCT 4 | $0.195 -15.0% 56K
|
Manufacturing
|
| O: -7.85%
H: 9.72%
C: 8.25%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.68%
H: 3.23%
C: 1.55%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.33%
H: 1.45%
C: 0.59%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.18%
H: 0.91%
C: 0.83%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 0.0%
H: 1.45%
C: -3.33%
IDYA | $37.1 -1.38% -1.4% 730K
|
Health Technology
|
| O: 0.47%
H: 2.93%
C: -1.6%
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
|
| O: -0.66%
H: 3.97%
C: -3.31%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.68%
H: 1.97%
C: 1.18%
melanoma companies market
Monoclonal Antibodies Clinical Trial Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-05 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 0.54%
H: 4.66%
C: -2.55%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.77%
H: 1.52%
C: 1.33%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 0.63%
H: 11.18%
C: 7.45%
companies pipeline trial
Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published: 2023-05-08 (Crawled : 15:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.11%
H: 0.72%
C: 0.3%
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 6.91%
H: 1.49%
C: -2.49%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -1.19%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 1.43%
H: 2.11%
C: -1.41%
companies report cancer pancreatic global
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
Published: 2022-11-10 (Crawled : 15:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.15%
H: 4.22%
C: 4.22%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.72%
H: 0.47%
C: -0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -4.59%
H: 3.28%
C: 3.06%
covid-19 chmp children vaccine positive
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Published: 2022-10-12 (Crawled : 15:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.41%
H: 2.49%
C: -0.14%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 3.4%
H: 4.91%
C: 2.06%
covid-19 fda children vaccine authorization
BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO
Published: 2022-09-09 (Crawled : 15:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 4.47%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.21%
H: 3.5%
C: 2.3%
bnt211 candidate car-t phase 1
Moderna Hits Pfizer and BioNTech with Patent Infringement Suits over COVID-19...
Published: 2022-08-26 (Crawled : 15:00) - biospace.com/
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.17%
H: 2.37%
C: -1.89%
covid-19 patent
Pfizer, BioNTech Seek EUA for Omicron Bivalent Shot, Fauci to Retire and More
Published: 2022-08-23 (Crawled : 15:00) - biospace.com/
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 1.14%
C: -0.84%
Battle of the Patents: Daiichi Sankyo, Seagen, Alnylam, CureVac, Pfizer, BioNTech & Moderna
Published: 2022-07-20 (Crawled : 15:00) - biospace.com/
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.16%
H: 1.95%
C: -0.24%
BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants
Published: 2022-01-11 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.41%
H: 5.99%
C: 1.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -3.03%
H: 0.0%
C: 0.0%
sars-cov-2 risk potential test
Worldwide RNA Therapeutics Industry - Featuring BioNTech, Moderna Therapeutics and CureVac Among Others
Published: 2021-07-15 (Crawled : 15:00) - prnewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.41%
H: 4.37%
C: 3.86%
therapeutics
Worldwide mRNA Vaccines and Therapeutics Industry to 2031 - Featuring Arcturus Therapeutics Holdings, BioNTech and CureVac Among Others
Published: 2021-06-01 (Crawled : 15:00) - prnewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -1.21%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.5%
H: 0.65%
C: 0.32%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -5.44%
H: 3.4%
C: 2.71%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.28%
H: 2.56%
C: 0.77%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: 1.3%
H: 1.69%
C: 1.15%
vaccine
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Published: 2020-12-21 (Crawled : 15:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.06%
H: 0.32%
C: 0.27%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 3.14%
H: 0.43%
C: -0.98%
covid vaccine positive chmp covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.